Frequently asked questions

We’ve got answers to some of the questions that are asked most often about growth-hormone deficiency and treatment options with Sogroya^® (somapacitan-beco) injection.

If you can’t find the answers to your questions here, be sure to speak with your doctor.

GROWTH HORMONE DEFICIENCY

What is growth hormone?

Hormones are chemical messengers produced in one part of the body that travel to another part of the body to create some sort of change. Growth hormone is made in the pituitary gland, at the base of the brain, and is important in helping children grow.

What is growth hormone deficiency?

A deficiency means there is not enough of something. Growth hormone deficiency means that your body is not making enough growth hormone.

How does growth hormone work?

When the pituitary gland releases growth hormone, this goes to the liver and causes a second hormone called insulin-like growth factor-1 (IGF-1) to be produced and released. Growth hormone and IGF-1 help keep the normal structure of bones, muscles, and many other organs.

What could happen if a growth hormone deficiency is not treated?

Lack of treatment for growth hormone deficiency could result in a child being significantly shorter than they otherwise would be when they reach adulthood. Adults who are not treated for GHD may have changes in the body such as weakening of bones, decrease in muscle, and increase in fat and cholesterol.

How is growth hormone deficiency diagnosed?

An endocrinologist, a doctor who specializes in the study of the body’s hormone system, can diagnose growth hormone deficiency. The doctor will ask questions about your health and growth history and about the health and growth history of your family. You will have a physical exam. The doctor may also order a growth hormone stimulation test, or "stim" test.

Are there any organizations focused on growth hormone deficiency?

There are several organizations dedicated to education, awareness, and advocacy for people with growth-related disorders. Visit the Growth Community page to find out more.

ABOUT SOGROYA^®

What is Sogroya^®?

Sogroya^® is a prescription medication that contains growth hormone, similar to the growth hormone made by the human body.

What can Sogroya^® treat?

Sogroya^® is a once-weekly treatment approved to treat children aged 2.5 years and older and adults who have been diagnosed with growth hormone deficiency.

How is Sogroya^® given?

The Sogroya^® pen is a prefilled device that is used to inject the medication under the skin. It can be injected in the upper arms, thigh, abdomen, or buttocks as instructed by your doctor. Be sure to rotate the injection site each week. Learn more about how to inject Sogroya^® by visiting our pen tutorial.

SOGROYA^® SAFETY AND SIDE EFFECTS

What are the possible side effects of Sogroya^®?

The most common side effects in children include: common cold, headache, fever, pain in extremity, and reaction to injection.

The most common side effects in adults include: back pain, joint pain, indigestion, sleep problems, dizziness, swelling of the tonsils (tonsillitis), vomiting, high blood pressure, increase in the level of an enzyme in your blood called creatine phosphokinase, weight gain, and low red blood cells (anemia).

These are not all the possible side effects of Sogroya^®. For more information, speak with your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects.

You may report side effects to the FDA at 1-800-332-1088. You may also report side effects to Novo Nordisk at 1-888-NOVO-444 (1-888-668-6444).

For full Prescribing Information, click here.

The device and storage of the device

How do I store the Sogroya^® pen?

Store the pen with the cap on, in the carton to protect it from light. Store Sogroya^® in a refrigerator between uses. Do not store in the freezer or next to the refrigerator cooling element. Sogroya^® may be stored temporarily at room temperature (up to 77 ºF) for up to 72 hours.^a Return Sogroya^® to the refrigerator after room temperature storage.

^aThe pen should be refrigerated (36 °F-46 °F). The pen can be taken in and out of a refrigerator as needed. The pen must be discarded 6 weeks after first use, or if it has been frozen, or in temperatures warmer than 86 °F. Keep Sogroya^® away from direct heat and light.

Do I need to mix and load medication cartridges?

All Sogroya^® pens come premixed and preloaded.

How can I tell if the medication is still good to use?

Growth hormone breaks down immediately when it goes bad. Look at the medication through the window on the pen. If it appears cloudy or discolored, call your pharmacy or NovoCare^® to inquire further. If it’s clear, and you’ve followed all storage requirements and precautions regarding the handling of the pen, the medication has not gone bad.

How big are the needles on Sogroya^® devices?

Sogroya^® pens are compatible with NovoFine^® needles, which are some of the thinnest needles we make. Our thinnest NovoFine^® needle in the United States is 32 gauge at the tip.^b,c

^bNeedles are sold separately and may require a prescription in some states.

^cDo not share your Sogroya^® pens and needles with another person even if the needle has been changed. You may give another person an infection or get an infection from them.

TREATMENT AND GROWTH EXPECTATIONS

How often will Sogroya^® need to be taken?

Sogroya^® needs to be taken once a week.

What happens if I miss a dose?

If within 3 days (72 hours) of missed dose: The dose should be taken as soon as possible, and then resume the usual dosing schedule.

If more than 3 days (72 hours) after missed dose: The dose should be skipped, and the next dose should be taken on the regularly scheduled day.

When will I start to see results from taking Sogroya^®?

Individual results can vary, so be sure to talk to your doctor about expectations for growth. To see data from the Sogroya^® clinical trial program, visit our results and safety pages for children and adults.

Insurance support and savings

What if I don’t have insurance or can’t pay for the medication?

Novo Nordisk, the maker of Sogroya^®, offers several different ways to help patients get, and stay on, therapy. These include the Sogroya^® savings card where patients with commercial insurance may pay as little as (“PALA”) $0 with an annual maximum cap of $3,000, the Patient Assistance Program (PAP), which provides free product to eligible patients who show financial need; and JumpStart™, which provides a limited supply of free Sogroya^® for insurance coverage delays for those who qualify. These programs have strict eligibility requirements. Call your NovoCare^® Case Manager (1-888-NOVO-444 or 1-888-668-6444) to find out whether you qualify.

Is there a cost for NovoCare^®?

No, NovoCare^® is a free program. Our Case Managers are dedicated to providing you with the information you need to deal with insurance matters and answering your questions about treatment.

What if your insurance claim is denied?

Your NovoCare^® Case Manager will support you through the appeals process.

Each situation is unique, and not all appeals will be approved. If your insurance company doesn’t cover Sogroya^®, NovoCare^® may be able to let you know what therapy it does cover.

What if something changes, such as a move or my insurance coverage?

If your insurance coverage or financial circumstances change, call NovoCare^®. We'll support you with the services you're eligible for.

What happens when it’s time to reauthorize?

Most insurance companies require prescriptions for medications such as Sogroya^® to be reauthorized every so often—every 6 or 12 months, for example. NovoCare^® will work with you and your doctor's office throughout the reauthorization process.

A familiar pen

The Sogroya^® pen is based on the FlexPro^® with more than 10 years of patient experience.

Meet the pen

Explore the science behind Sogroya^®

The path to fewer injection days with Sogroya^® starts with albumin-binding prolongation technology.

Discover more

Show more Show less

Important Safety Information

Do not use Sogroya^® if:

you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
you have cancer or other tumors
you are allergic to somapacitan-beco or any of the ingredients in Sogroya^®
your healthcare provider tells you that you have certain types of eye problems caused by diabetes
you are a child with closed bone growth plates
you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)

Before taking Sogroya^®, tell your healthcare provider about all of your medical conditions, including if you:

have had heart or stomach surgery, trauma, or serious breathing problems
have had cancer or any tumor
have diabetes
have adrenal gland problems
are taking replacement therapy with glucocorticoids
have thyroid gland problems
have liver problems
are a child with a history of worsening of curvature of the spine (scoliosis)
are pregnant or plan to become pregnant. It is not known if Sogroya^® will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant
are breastfeeding or plan to breastfeed. It is not known if Sogroya^® passes into your breast milk. You and your healthcare provider should decide if you will take Sogroya^® while you breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Sogroya^® may affect the way some medicines work, and some medicines may affect how Sogroya^® works.

How should I use Sogroya^®?

Use Sogroya^® exactly as your healthcare provider tells you to
Use Sogroya^® 1 time each week
If you miss a dose of Sogroya^®, the missed dose can be taken within 3 days (72 hours) after the scheduled dosing day. One-time weekly dosing for the next dose can be started again on the regularly scheduled dosing day
If more than 3 days (72 hours) have passed, skip the missed dose, and take your next dose on the regularly scheduled dosing day
Sogroya^® pens are for use by 1 person only
Do not share your Sogroya^® pens and needles with another person, even if the needle has been changed. You may give another person an infection or get an infection from them

What are the possible side effects of Sogroya^®?

Sogroya^® may cause serious side effects, including:

high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma, or serious breathing problems
increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. You or your child’s healthcare provider will need to monitor you or your child for a return of cancer or a tumor. Contact the healthcare provider if you or your child start to have sudden changes in behavior, headaches, vision problems, or changes in moles, birthmarks, or the color of your or your child’s skin
new or worsening high blood sugar or diabetes. You or your child’s blood sugar may need to be monitored during treatment with Sogroya^®
increase in pressure in the skull. If you or your child have headaches, eye problems, nausea or vomiting, contact the healthcare provider
serious allergic reactions. Get medical help right away if you or your child have the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness, or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, sweating
your or your child’s body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your or your child’s joints or muscles or nerve problems that cause pain, burning or tingling in the hands, arms, legs, and feet. Tell your or your child’s healthcare provider if you or your child have any of these signs or symptoms of fluid retention
decrease in a hormone called cortisol. The healthcare provider will do blood tests to check your or your child’s cortisol levels. Tell your or your child’s healthcare provider if you or your child have darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
decrease in thyroid hormone levels. Decreased thyroid hormone levels may affect how well Sogroya^® works. The healthcare provider will do blood tests to check you or your child’s thyroid hormone levels
severe and constant abdominal pain. This could be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
loss of fat and tissue weakness in the area of skin you or your child inject. Talk to your or your child’s healthcare provider about rotating the areas where you or your child inject Sogroya^®
worsening of curvature of the spine in children (scoliosis)
hip and knee pain or a limp in children (slipped capital femoral epiphysis)
high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems, including sleep apnea
increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood. You or your child’s healthcare provider will do blood tests to check this

The most common side effects of Sogroya^® in children include: common cold, headache, fever, pain in extremity, and reaction to injection

The most common side effects of Sogroya^® in adults include: back pain, joint pain, indigestion, sleep problems, dizziness, swelling of the tonsils (tonsillitis), vomiting, high blood pressure, increase in the level of an enzyme in your blood called creatine phosphokinase, weight gain, and low red blood cells (anemia)

Please click here for Sogroya^® Prescribing Information.

Sogroya^® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

What is Sogroya^®?

Sogroya^® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body.
It is given by injection under the skin (subcutaneous) and is used to treat adults and children 2.5 years and older who do not make enough growth hormone.

What is Sogroya^®?

Sogroya^® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body.
It is given by injection under the skin (subcutaneous) and is used to treat adults and children 2.5 years and older who do not make enough growth hormone.

Show more Show less

What is Sogroya^®?

Sogroya^® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body.
It is given by injection under the skin (subcutaneous) and is used to treat adults and children 2.5 years and older who do not make enough growth hormone.

What is Sogroya^®?

Sogroya^® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body.
It is given by injection under the skin (subcutaneous) and is used to treat adults and children 2.5 years and older who do not make enough growth hormone.

Important Safety Information

Do not use Sogroya^® if:

you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
you have cancer or other tumors
you are allergic to somapacitan-beco or any of the ingredients in Sogroya^®
your healthcare provider tells you that you have certain types of eye problems caused by diabetes
you are a child with closed bone growth plates
you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)

Before taking Sogroya^®, tell your healthcare provider about all of your medical conditions, including if you:

have had heart or stomach surgery, trauma, or serious breathing problems
have had cancer or any tumor
have diabetes
have adrenal gland problems
are taking replacement therapy with glucocorticoids
have thyroid gland problems
have liver problems
are a child with a history of worsening of curvature of the spine (scoliosis)
are pregnant or plan to become pregnant. It is not known if Sogroya^® will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant
are breastfeeding or plan to breastfeed. It is not known if Sogroya^® passes into your breast milk. You and your healthcare provider should decide if you will take Sogroya^® while you breastfeed

How should I use Sogroya^®?

Use Sogroya^® exactly as your healthcare provider tells you to
Use Sogroya^® 1 time each week
If you miss a dose of Sogroya^®, the missed dose can be taken within 3 days (72 hours) after the scheduled dosing day. One-time weekly dosing for the next dose can be started again on the regularly scheduled dosing day
If more than 3 days (72 hours) have passed, skip the missed dose, and take your next dose on the regularly scheduled dosing day
Sogroya^® pens are for use by 1 person only
Do not share your Sogroya^® pens and needles with another person, even if the needle has been changed. You may give another person an infection or get an infection from them

What are the possible side effects of Sogroya^®?

Sogroya^® may cause serious side effects, including:

high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma, or serious breathing problems
increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. You or your child’s healthcare provider will need to monitor you or your child for a return of cancer or a tumor. Contact the healthcare provider if you or your child start to have sudden changes in behavior, headaches, vision problems, or changes in moles, birthmarks, or the color of your or your child’s skin
new or worsening high blood sugar or diabetes. You or your child’s blood sugar may need to be monitored during treatment with Sogroya^®
increase in pressure in the skull. If you or your child have headaches, eye problems, nausea or vomiting, contact the healthcare provider
serious allergic reactions. Get medical help right away if you or your child have the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness, or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, sweating
your or your child’s body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your or your child’s joints or muscles or nerve problems that cause pain, burning or tingling in the hands, arms, legs, and feet. Tell your or your child’s healthcare provider if you or your child have any of these signs or symptoms of fluid retention
decrease in a hormone called cortisol. The healthcare provider will do blood tests to check your or your child’s cortisol levels. Tell your or your child’s healthcare provider if you or your child have darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
decrease in thyroid hormone levels. Decreased thyroid hormone levels may affect how well Sogroya^® works. The healthcare provider will do blood tests to check you or your child’s thyroid hormone levels
severe and constant abdominal pain. This could be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
loss of fat and tissue weakness in the area of skin you or your child inject. Talk to your or your child’s healthcare provider about rotating the areas where you or your child inject Sogroya^®
worsening of curvature of the spine in children (scoliosis)
hip and knee pain or a limp in children (slipped capital femoral epiphysis)
high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems, including sleep apnea
increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood. You or your child’s healthcare provider will do blood tests to check this

The most common side effects of Sogroya^® in children include: common cold, headache, fever, pain in extremity, and reaction to injection

Please click here for Sogroya^® Prescribing Information.

Sogroya^® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Important Safety Information

Do not use Sogroya^® if:

you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
you have cancer or other tumors
you are allergic to somapacitan-beco or any of the ingredients in Sogroya^®
your healthcare provider tells you that you have certain types of eye problems caused by diabetes
you are a child with closed bone growth plates
you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)

Before taking Sogroya^®, tell your healthcare provider about all of your medical conditions, including if you:

have had heart or stomach surgery, trauma, or serious breathing problems
have had cancer or any tumor
have diabetes
have adrenal gland problems
are taking replacement therapy with glucocorticoids
have thyroid gland problems
have liver problems
are a child with a history of worsening of curvature of the spine (scoliosis)
are pregnant or plan to become pregnant. It is not known if Sogroya^® will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant
are breastfeeding or plan to breastfeed. It is not known if Sogroya^® passes into your breast milk. You and your healthcare provider should decide if you will take Sogroya^® while you breastfeed

How should I use Sogroya^®?

Use Sogroya^® exactly as your healthcare provider tells you to
Use Sogroya^® 1 time each week
If you miss a dose of Sogroya^®, the missed dose can be taken within 3 days (72 hours) after the scheduled dosing day. One-time weekly dosing for the next dose can be started again on the regularly scheduled dosing day
If more than 3 days (72 hours) have passed, skip the missed dose, and take your next dose on the regularly scheduled dosing day
Sogroya^® pens are for use by 1 person only
Do not share your Sogroya^® pens and needles with another person, even if the needle has been changed. You may give another person an infection or get an infection from them

What are the possible side effects of Sogroya^®?

Sogroya^® may cause serious side effects, including:

high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma, or serious breathing problems
increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. You or your child’s healthcare provider will need to monitor you or your child for a return of cancer or a tumor. Contact the healthcare provider if you or your child start to have sudden changes in behavior, headaches, vision problems, or changes in moles, birthmarks, or the color of your or your child’s skin
new or worsening high blood sugar or diabetes. You or your child’s blood sugar may need to be monitored during treatment with Sogroya^®
increase in pressure in the skull. If you or your child have headaches, eye problems, nausea or vomiting, contact the healthcare provider
serious allergic reactions. Get medical help right away if you or your child have the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness, or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, sweating
your or your child’s body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your or your child’s joints or muscles or nerve problems that cause pain, burning or tingling in the hands, arms, legs, and feet. Tell your or your child’s healthcare provider if you or your child have any of these signs or symptoms of fluid retention
decrease in a hormone called cortisol. The healthcare provider will do blood tests to check your or your child’s cortisol levels. Tell your or your child’s healthcare provider if you or your child have darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
decrease in thyroid hormone levels. Decreased thyroid hormone levels may affect how well Sogroya^® works. The healthcare provider will do blood tests to check you or your child’s thyroid hormone levels
severe and constant abdominal pain. This could be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
loss of fat and tissue weakness in the area of skin you or your child inject. Talk to your or your child’s healthcare provider about rotating the areas where you or your child inject Sogroya^®
worsening of curvature of the spine in children (scoliosis)
hip and knee pain or a limp in children (slipped capital femoral epiphysis)
high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems, including sleep apnea
increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood. You or your child’s healthcare provider will do blood tests to check this

The most common side effects of Sogroya^® in children include: common cold, headache, fever, pain in extremity, and reaction to injection

Please click here for Sogroya^® Prescribing Information.

Sogroya^® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Important Safety Information

Do not use Sogroya^® if:

you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
you have cancer or other tumors
you are allergic to somapacitan-beco or any of the ingredients in Sogroya^®
your healthcare provider tells you that you have certain types of eye problems caused by diabetes
you are a child with closed bone growth plates
you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)

Before taking Sogroya^®, tell your healthcare provider about all of your medical conditions, including if you:

have had heart or stomach surgery, trauma, or serious breathing problems
have had cancer or any tumor
have diabetes
have adrenal gland problems
are taking replacement therapy with glucocorticoids
have thyroid gland problems
have liver problems
are a child with a history of worsening of curvature of the spine (scoliosis)
are pregnant or plan to become pregnant. It is not known if Sogroya^® will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant
are breastfeeding or plan to breastfeed. It is not known if Sogroya^® passes into your breast milk. You and your healthcare provider should decide if you will take Sogroya^® while you breastfeed

How should I use Sogroya^®?

Use Sogroya^® exactly as your healthcare provider tells you to
Use Sogroya^® 1 time each week
If you miss a dose of Sogroya^®, the missed dose can be taken within 3 days (72 hours) after the scheduled dosing day. One-time weekly dosing for the next dose can be started again on the regularly scheduled dosing day
If more than 3 days (72 hours) have passed, skip the missed dose, and take your next dose on the regularly scheduled dosing day
Sogroya^® pens are for use by 1 person only
Do not share your Sogroya^® pens and needles with another person, even if the needle has been changed. You may give another person an infection or get an infection from them

What are the possible side effects of Sogroya^®?

Sogroya^® may cause serious side effects, including:

high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma, or serious breathing problems
increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. You or your child’s healthcare provider will need to monitor you or your child for a return of cancer or a tumor. Contact the healthcare provider if you or your child start to have sudden changes in behavior, headaches, vision problems, or changes in moles, birthmarks, or the color of your or your child’s skin
new or worsening high blood sugar or diabetes. You or your child’s blood sugar may need to be monitored during treatment with Sogroya^®
increase in pressure in the skull. If you or your child have headaches, eye problems, nausea or vomiting, contact the healthcare provider
serious allergic reactions. Get medical help right away if you or your child have the following symptoms: swelling of your face, lips, mouth, or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness, or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, sweating
your or your child’s body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your or your child’s joints or muscles or nerve problems that cause pain, burning or tingling in the hands, arms, legs, and feet. Tell your or your child’s healthcare provider if you or your child have any of these signs or symptoms of fluid retention
decrease in a hormone called cortisol. The healthcare provider will do blood tests to check your or your child’s cortisol levels. Tell your or your child’s healthcare provider if you or your child have darkening of the skin, severe fatigue, dizziness, weakness, or weight loss
decrease in thyroid hormone levels. Decreased thyroid hormone levels may affect how well Sogroya^® works. The healthcare provider will do blood tests to check you or your child’s thyroid hormone levels
severe and constant abdominal pain. This could be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain
loss of fat and tissue weakness in the area of skin you or your child inject. Talk to your or your child’s healthcare provider about rotating the areas where you or your child inject Sogroya^®
worsening of curvature of the spine in children (scoliosis)
hip and knee pain or a limp in children (slipped capital femoral epiphysis)
high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems, including sleep apnea
increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood. You or your child’s healthcare provider will do blood tests to check this

The most common side effects of Sogroya^® in children include: common cold, headache, fever, pain in extremity, and reaction to injection

Please click here for Sogroya^® Prescribing Information.

Sogroya^® is a prescription medication. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

What is Sogroya^®?

Sogroya^® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body.
It is given by injection under the skin (subcutaneous) and is used to treat adults and children 2.5 years and older who do not make enough growth hormone.

What is Sogroya^®?

Sogroya^® (somapacitan-beco) injection 5 mg, 10 mg or 15 mg is a prescription medicine that contains human growth hormone, the same growth hormone made by the body.
It is given by injection under the skin (subcutaneous) and is used to treat adults and children 2.5 years and older who do not make enough growth hormone.

Frequently asked questions

Insurance support and savings

Important Safety Information

Do not use Sogroya® if:

Before taking Sogroya®, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Sogroya®?

What are the possible side effects of Sogroya®?

Sogroya® may cause serious side effects, including:

What is Sogroya®?

What is Sogroya®?

What is Sogroya®?

What is Sogroya®?

Important Safety Information

Do not use Sogroya® if:

Before taking Sogroya®, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Sogroya®?

What are the possible side effects of Sogroya®?

Sogroya® may cause serious side effects, including:

Important Safety Information

Do not use Sogroya® if:

Before taking Sogroya®, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Sogroya®?

What are the possible side effects of Sogroya®?

Sogroya® may cause serious side effects, including:

Important Safety Information

Do not use Sogroya® if:

Before taking Sogroya®, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Sogroya®?

What are the possible side effects of Sogroya®?

Sogroya® may cause serious side effects, including:

What is Sogroya®?

What is Sogroya®?

Do not use Sogroya^® if:

Before taking Sogroya^®, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Sogroya^®?

What are the possible side effects of Sogroya^®?

Sogroya^® may cause serious side effects, including:

What is Sogroya^®?

What is Sogroya^®?

What is Sogroya^®?

What is Sogroya^®?

Do not use Sogroya^® if:

Before taking Sogroya^®, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Sogroya^®?

What are the possible side effects of Sogroya^®?

Sogroya^® may cause serious side effects, including:

Do not use Sogroya^® if:

Before taking Sogroya^®, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Sogroya^®?

What are the possible side effects of Sogroya^®?

Sogroya^® may cause serious side effects, including:

Do not use Sogroya^® if:

Before taking Sogroya^®, tell your healthcare provider about all of your medical conditions, including if you:

How should I use Sogroya^®?

What are the possible side effects of Sogroya^®?

Sogroya^® may cause serious side effects, including:

What is Sogroya^®?

What is Sogroya^®?